CSMD1 and glioma: A Western blot analysis performed on subfractionated U-118 and U-87 glioma cells following TNF treatment demonstrated that pP65-Ser536 was upregulated in the cytoplasmic fraction of Ctrl clones compared to CSMD1-overexpressing clones.